Evidence Hub

Patient with Systemic Lupus Erythematosus Combined with Erosive Arthritis was Treated Successfully with Tocilizumab: A Case Report

M. Kim, Sunghoon Park, C. Suh, Ju-Yang Jung, Hyoun-Ah Kim

2018

5 citations

Abstract

Received:August 11, 2017, Revised:August 29, 2017, Accepted:October 25, 2017 Corresponding to:Hyoun-Ah Kim http://orcid.org/0000-0003-2609-3367 Department of Rheumatology, Ajou University School of Medicine, 164 WorldCup-ro, Yeongtong-gu, Suwon 16499, Korea. E-mail:[email protected] Copyright c 2018 by The Korean College of Rheumatology. All rights reserved. This is a Open Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited. Case Report pISSN: 2093-940X, eISSN: 2233-4718 Journal of Rheumatic Diseases Vol. 25, No. 2, April, 2018 https://doi.org/10.4078/jrd.2018.25.2.144

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free